title: Continuous intrathecal perfusion of methotrexate for carcinomatous meningitis with pharmacokinetic studies: two case studies.
authors.affiliation: Medical Oncology Department, Paul Strauss Cancer Center, Strasbourg, France.
authors.forename: T
authors.initials: T
authors.lastname: Petit
authors.forename: P
authors.initials: P
authors.lastname: Dufour
authors.forename: A S
authors.initials: AS
authors.lastname: Korganov
authors.forename: F
authors.initials: F
authors.lastname: Maloisel
authors.forename: F
authors.initials: F
authors.lastname: Oberling
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000556:secondary*; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008577:Meningeal Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008727:Methotrexate / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate